Skip to content

Clinical trials

Completed Phase 1 Endocrine System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Phase: Phase 1 Status: Completed Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20071
20082
20092
20101
20111
20131
20191
20201
20211
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Pittsburgh3
Goldfinch Bio, Inc.2
Merck Sharp & Dohme LLC2
University Hospital, Basel, Switzerland2
Beta-Stim Ltd.1
CRISPR Therapeutics AG1
Corbus Pharmaceuticals Inc.1
Corcept Therapeutics1
Eli Lilly and Company1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases17
Diabetes Mellitus8
Metabolic Diseases8
Glucose Metabolism Disorders7
Diabetes Mellitus, Type 26
Musculoskeletal Diseases3
Osteoporosis3
Body Weight2
Diabetes Complications2
Diabetic Nephropathies2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.